biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	0C53FD38-5468-4017-A0CE-F36F473F4A09
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-2Y-A9H9-01A-21R
biospecimen__bio__bcr_portion_barcode	TCGA-2Y-A9H9-01A-21
biospecimen__bio__bcr_sample_barcode	TCGA-2Y-A9H9-01A
biospecimen__bio__biospecimen_barcode_bottom	0167788079
biospecimen__bio__day_of_creation	17
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-2Y-A9H9.36C343AC-443B-4196-8B6D-7D9213F2DAE1.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A39J
biospecimen__bio__plate_row	E
biospecimen__bio__quantity	3.00
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-2Y-A9H9
biospecimen__shared__patient_id	A9H9
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-2Y-A9H9-A67255
clinical__ablation__bcr_ablation_uuid	36E9FF5F-3F7D-48FC-B27F-3D2A7718C96B
clinical__ablation__days_to_embolization_performed	434
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Doxorubicin
clinical__ablation__embolization_therapy_drug_name_other	lipiodol/doxyrubicin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	embospheres
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	48126058-F6B2-4650-A0DA-6B038D8F468E
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.7
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	7
clinical__chol_lihc_shared__fetoprotein_outcome_value	12
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	11.5
clinical__chol_lihc_shared__platelet_result_lower_limit	143
clinical__chol_lihc_shared__platelet_result_upper_limit	382
clinical__chol_lihc_shared__prothrombin_time_result_value	11
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__clin_shared__age_at_initial_pathologic_diagnosis	70
clinical__clin_shared__bcr_followup_barcode	TCGA-2Y-A9H9-F69092
clinical__clin_shared__bcr_followup_uuid	54F0058B-7B9D-4D76-B355-451F00869416
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	203
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	701
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-2Y-A9H9-D67254
clinical__rx__bcr_drug_uuid	3A75D221-5FD8-459B-B5CC-CC8FA03BD3F2
clinical__rx__days_to_drug_therapy_start	1017
clinical__rx__drug_name	Naxavar
clinical__rx__therapy_ongoing	YES
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	88dea3b8-01b8-4e48-b61f-7e1c7e4ff30e
gdc__aliquots__concentration	0.15
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-2Y-A9H9-01A-21R-A39J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	5f5a1a91-a8d3-4d84-923f-8799c7155517
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.89
gdc__analytes__analyte_id	4c36b3e1-d2b6-4787-a1ac-4ed66ecc1430
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	efc3e5e4-0d8e-4bef-a259-29f8ed21684f
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:30:09.587137-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	88020936-8e46-5821-9268-50599a85b42f
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1941
gdc__diagnoses__age_at_diagnosis	25670
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25670.0
gdc__diagnoses__days_to_last_follow_up	697.0
gdc__diagnoses__diagnosis_id	49298ff4-8b2b-5191-9639-aa3d3b2b8be6
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	27.77427092538821
gdc__exposures__exposure_id	fda03578-205c-53d1-bfa4-a032b9896c72
gdc__exposures__height	178.0
gdc__exposures__weight	88.0
gdc__file_id	a62da189-4c70-41e9-800c-1be6b22b9420
gdc__file_name	7d11f015-f4ee-439e-87b5-e3844e6d1f04.mirbase21.mirnas.quantification.txt
gdc__file_size	50181
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	8a641ba429531ae484ffa08fd853dd56
gdc__portions__is_ffpe	false
gdc__portions__portion_id	6e956787-b35e-400e-a8eb-d3f3f218413b
gdc__portions__portion_number	21
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	731
gdc__samples__initial_weight	120.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	36C343AC-443B-4196-8B6D-7D9213F2DAE1
gdc__samples__sample_id	42d4cda4-bf55-41b5-9b91-04132a081e13
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	2.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	3.0
gdc__slides__percent_tumor_cells	95.0
gdc__slides__percent_tumor_nuclei	96.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	18d7b9cf-79bb-470e-a0dc-a1306bd8dde3
gdc__submitter_id	mirna_swap_dr11_76_MirnaExpressionff9b9c4c-ca03-4ddc-9ba8-eddf601b7ee1_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	2Y
gdc__tissue_source_site__name	Moffitt Cancer Center
gdc__tissue_source_site__tissue_source_site_id	33e340f9-a97a-56eb-a3e6-aad831681cb4
gdc__treatments__treatment_id	982687d0-9c05-56dc-9122-ab994752b558
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:56.317+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/88dea3b8-01b8-4e48-b61f-7e1c7e4ff30e-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/88dea3b8-01b8-4e48-b61f-7e1c7e4ff30e-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129552
manually_curated__local_md5	667cb1ec316715f3120d3f371cbf1392
manually_curated__opengdc_download_date	2018-10-16T17:11:18.000327+02:00
manually_curated__opengdc_file_md5	cbcdbf7d85ba7d6108f35aaa81d601b7
manually_curated__opengdc_file_size	50180
manually_curated__opengdc_id	88dea3b8-01b8-4e48-b61f-7e1c7e4ff30e-meq
manually_curated__origin_file_size	129552
manually_curated__origin_last_modified_date	Tue Oct 16 17:42:00 CEST 2018
manually_curated__origin_md5	667cb1ec316715f3120d3f371cbf1392
manually_curated__tissue_status	tumoral
